| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327481 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
Immunohistochemical studies may be needed to differentiate among the alternative diagnoses of malignant melanoma, metastatic carcinoma, and epithelioid sarcoma. Additional cases are needed to develop optimal management strategies and to predict prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Masafumi Toyoshima, Chikako Okamura, Hitoshi Niikura, Kiyoshi Ito, Nobuo Yaegashi,